WASHINGTON (AP) — U.S. health authorities have eased safety restrictions on an experimental drug to treat Ebola, a move that could clear the way for its use in patients infected with the deadly virus.

Canadian drugmaker Tekmira Pharmaceuticals Corp. said the U.S. Food and Drug Administration modified a hold recently placed on the company’s drug after safety issues emerged in human testing.

Recommended Stories

Vance puts American sovereignty at center of closing midterm argument

Trump offers $1 million reward for tips resulting in voter fraud convictions

Vance leads Rubio by double digits in early 2028 Republican poll